HeartFlow’s current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more ...

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Backed by Bain Capital, the health technology startup makes 3D models of people's hearts to help diagnose diseases. Here's ...

(Reuters) -Cardiac diagnostic software maker Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in ...

HeartFlow’s AI-based CAD platform targets a large market with strong adoption, but IPO valuation and risks warrant caution.

Heartflow announced today that it closed its upsized initial public offering (IPO) with proceeds totaling approximately $364.2 million.

Heartflow, a company involved in AI technology for coronary artery disease, went public on Friday under the ticker symbol HTFL, raising $316.7 million with its initial public offering. Late last week, ...

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S. initial public offering on Thursday, at a time when it looks to tap into ...

Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...